Literature DB >> 10344759

Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.

T Kamijo1, E van de Kamp, M J Chong, F Zindy, J A Diehl, C J Sherr, P J McKinnon.   

Abstract

The alternative reading frame product (p19ARF) of the mouse INK4a/ARF locus is induced by oncoproteins such as Myc and E1A as part of a checkpoint response that limits cell cycle progression in response to hyperproliferative signals. ARF binds directly to Mdm2 to prevent down-regulation of p53 and thereby promotes p53-dependent transcription and cell cycle arrest. However, ARF is not required for p53 induction in response to ionizing radiation or other forms of DNA damage. Animals lacking a functional ataxia telangiectasia (Atm) gene are exquisitely sensitive to ionizing radiation; Atm-null mouse embryo fibroblasts (MEFs) undergo premature replicative arrest, which is relieved by the loss of p53. Here we show that the loss of ARF expands the life expectancy of Atm-null MEFs, but alters neither the sensitivity of Atm-null mice to ionizing radiation nor their propensity to develop lymphomas early in life. Therefore, whereas ARF and Atm signal to p53 through distinct pathways, the loss of ARF can modify p53-dependent features of the Atm-null phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344759

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

Authors:  G Y Wang; C N Wood; J A Dolorito; E Libove; E H Epstein
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

2.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.

Authors:  Y Lu; H Lian; P Sharma; N Schreiber-Agus; R G Russell; L Chin; G T van der Horst; D B Bregman
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  MKK7 and ARF: new players in the DNA damage response scenery.

Authors:  Athanassios Kotsinas; Panagiota Papanagnou; Panagiotis Galanos; Daniel Schramek; Paul Townsend; Josef M Penninger; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

6.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

7.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

8.  Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Authors:  Frederique Zindy; Richard T Williams; Troy A Baudino; Jerold E Rehg; Stephen X Skapek; John L Cleveland; Martine F Roussel; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

9.  Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.

Authors:  Kamil R Kranc; Simon D Bamforth; José Bragança; Chris Norbury; Maarten van Lohuizen; Shoumo Bhattacharya
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  INK4a/ARF limits the expansion of cells suffering from replication stress.

Authors:  Angela Monasor; Matilde Murga; Andres J Lopez-Contreras; Carolina Navas; Gonzalo Gomez; David G Pisano; Oscar Fernandez-Capetillo
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.